Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
                                    Invitrogen™ LCOR Polyclonal Antibody
 
                                    
                                    
                                    
                                    
                                
                            
                            
                            
                            
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA556741
Description
Immunogen sequence: HGQHLILSRE ASWAKPHYEF NLSRMKFRGN GALSNISDLP FLAENSAFPK MALQAKQDGK KDVSHSSPVD LKIPQVRGMD LSWE Highest antigen sequence identity to the following orthologs: Mouse - 94%, Rat - 93%.
LCOR is a transcriptional corepressor widely expressed in fetal and adult tissues that is recruited to agonist-bound nuclear receptors through a single LxxLL motif, also referred to as a nuclear receptor (NR) box. 
            Specifications
| LCOR | |
| Polyclonal | |
| Unconjugated | |
| LCOR | |
| 3110023F06Rik; A630025C20Rik; C10orf12; KIAA1795; Lcor; ligand dependent nuclear receptor corepressor; ligand-dependent corepressor; Mblk1-related protein 2; Mblk1-related protein-2; mKIAA1795; MLR2; RGD1311704; transcription factor MLR2 | |
| Rabbit | |
| Antigen Affinity Chromatography | |
| RUO | |
| 84458 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid | 
| Western Blot | |
| 0.1 mg/mL | |
| PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
| Q96JN0 | |
| LCOR | |
| Recombinant protein corresponding to Human LCOR. Recombinant protein control fragment (Product #RP-95761). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG | 
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            Spot an opportunity for improvement?Share a Content Correction
            